scholarly journals Peste des Petits Ruminants Virus Infection at the Wildlife–Livestock Interface in the Greater Serengeti Ecosystem, 2015–2019

Viruses ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 838
Author(s):  
Bryony A. Jones ◽  
Mana Mahapatra ◽  
Daniel Mdetele ◽  
Julius Keyyu ◽  
Francis Gakuya ◽  
...  

Peste des petits ruminants (PPR) is a viral disease of goats and sheep that occurs in Africa, the Middle East and Asia with a severe impact on livelihoods and livestock trade. Many wild artiodactyls are susceptible to PPR virus (PPRV) infection, and some outbreaks have threatened endangered wild populations. The role of wild species in PPRV epidemiology is unclear, which is a knowledge gap for the Global Strategy for the Control and Eradication of PPR. These studies aimed to investigate PPRV infection in wild artiodactyls in the Greater Serengeti and Amboseli ecosystems of Kenya and Tanzania. Out of 132 animals purposively sampled in 2015–2016, 19.7% were PPRV seropositive by ID Screen PPR competition enzyme-linked immunosorbent assay (cELISA; IDvet, France) from the following species: African buffalo, wildebeest, topi, kongoni, Grant’s gazelle, impala, Thomson’s gazelle, warthog and gerenuk, while waterbuck and lesser kudu were seronegative. In 2018–2019, a cross-sectional survey of randomly selected African buffalo and Grant’s gazelle herds was conducted. The weighted estimate of PPRV seroprevalence was 12.0% out of 191 African buffalo and 1.1% out of 139 Grant’s gazelles. All ocular and nasal swabs and faeces were negative by PPRV real-time reverse transcription-polymerase chain reaction (RT-qPCR). Investigations of a PPR-like disease in sheep and goats confirmed PPRV circulation in the area by rapid detection test and/or RT-qPCR. These results demonstrated serological evidence of PPRV infection in wild artiodactyl species at the wildlife–livestock interface in this ecosystem where PPRV is endemic in domestic small ruminants. Exposure to PPRV could be via spillover from infected small ruminants or from transmission between wild animals, while the relatively low seroprevalence suggests that sustained transmission is unlikely. Further studies of other major wild artiodactyls in this ecosystem are required, such as impala, Thomson’s gazelle and wildebeest.

Author(s):  
Gabriel M. Shirima ◽  
John S. Kunda

Between 2005 and 2006, a cross-sectional survey was carried out in domestic ruminants in agropastoral communities of Serengeti district, Tanzania to determine the seroprevalence of brucellosis in domestic–wildlife interface villages. Both the Rose Bengal Plate Test (RBPT) and Competitive Enzyme Linked-immunosorbent Assay (c-ELISA) were used to analyse 82 human and 413 livestock sera from four randomly selected villages located along game reserve areas of Serengeti National Park. Although both cattle (288) and small ruminants (125) were screened, seropositivity was detected only in cattle. The overall seroprevalence based on c-ELISA as a confirmatory test was 5.6%. In cattle both age and sex were not statistically associated with brucellosis seropositivity (P = 0.63; 95% CI = 0.03, 0.8 and 0.33; 95% CI = 0.6, 3.7, respectively). Overall herd level seropositivity was 46.7% (n = 7), ranging from 25% to 66.7% (n = 4–10). Each village had at least one brucellosis seropositive herd. None of the 82 humans tested with both RBPT and c-ELISA were seropositive. Detecting Brucella infection in cattle in such areas warrants further investigation to establish the circulating strains for eventual appropriate control interventions in domestic animals.


2005 ◽  
Vol 12 (4) ◽  
pp. 542-547 ◽  
Author(s):  
Kang-Seuk Choi ◽  
Jin-Ju Nah ◽  
Young-Joon Ko ◽  
Shien-Young Kang ◽  
Nam-In Jo

ABSTRACT Peste des petits ruminants (PPR) is a contagious viral disease of small ruminants that is of economic importance in Africa, the Middle East, and Asia. We developed a rapid competitive enzyme-linked immunosorbent assay (rapid c-ELISA) for the diagnosis and surveillance of PPR. This assay detects PPR virus (PPRV) antibodies in serum samples by quantifying the amount of monoclonal antibody (MAb) P-3H12 after 30 min of incubation of a serum-MAb conjugate mixture on plates coated with a PPRV recombinant nucleocapsid protein (rPPRV-N). We tested 249 PPRV-positive serum samples and 733 PPRV-negative serum samples from field ruminants. The threshold of percent inhibition (PI) was determined to be <50 on the basis of the mean PI plus 3 standard deviations for sera from PPRV-negative ruminants. The relative specificity and sensitivity of the rapid c-ELISA were 98.5% (722 of 733 serum samples) and 93.4% (234 of 249 serum samples), respectively. The rapid c-ELISA sensitively detected PPRV antibodies in hyperimmune sera (virus neutralization test [VNT] titer, >512), even at dilutions ≥512 in normal goat serum, and as early as 6 to 13 days postinfection from 12 goats, each of which was infected with one of the four PPRV lineages. Hyperimmune sera from animals experimentally vaccinated with rinderpest virus gave positive results by the rapid c-ELISA when the rinderpest virus VNT titers were >512, although the rapid c-ELISA titers were very low (2 to 16). However, the rapid c-ELISA was negative when the rinderpest virus VNT titer was ≤128. The rapid c-ELISA developed in the present work provides a short turnaround time and could be a useful tool for the diagnosis of PPR and screening for PPRV in the field.


Author(s):  
Timothy Y. Woma ◽  
Pius S. Ekong ◽  
Dauda G. Bwala ◽  
John O. Ibu ◽  
Louisa Ta’ama ◽  
...  

Peste des petits ruminants, caused by the peste des petits ruminants virus (PPRV), is a highly contagious and economically important transboundary viral disease of domestic and wild small ruminants and a major hindrance to small-ruminant production in Nigeria. The seroprevalence and distribution of PPRV antibodies in small ruminants in rural households, farms, live animal markets and slaughter slabs across the six different agro-ecological zones of Nigeria were determined. A total of 4548 serum samples from 3489 goats and 1059 sheep were collected in 12 states. A PPRV competitive enzyme-linked immunosorbent assay was used to test the samples and the data analysed with R statistical software version 3.0.1. The study animals included all ages and both sexes. The overall prevalence estimate of sera positive for PPRV antibodies was 23.16% (n = 1018 positive samples per 4548 total samples, 95% confidence interval: 21.79% – 24.57%). There were significant differences in the seroprevalence between the states (p = 0.001). Taraba State had the highest seroprevalence of 29.51%, whilst the lowest seroprevalence of 14.52% was observed in Cross River State. There were no significant differences in the PPRV seroprevalence between male and female animals (p = 0.571), age (p = 0.323) and between species (p = 0.639). These data indicate the current seroprevalence to PPRV in the small-ruminant population in Nigeria.


2020 ◽  
Vol 76 (03) ◽  
pp. 6380-2020
Author(s):  
WIESŁAW NIEDBALSKI

Peste des petits ruminants (PPR) is a highly contagious viral disease of domestic and wild small ruminants caused by the peste des petits ruminants virus (PPRV), which belongs to the genus Morbilivirus in the family Paramyxoviridae. The PPRV causes disease in goats and sheep, as well as in wild ruminants, such as gazelle, deer, antelope, Nubian ibex, gemsbok and others. PPR was first recorded in early 1942 in Ivory Coast, West Africa, and spread to around 70 countries in Africa, the Middle East and Asia – regions that are home to over 80% of the world’s sheep and goats. Until 2018, PPR had never been detected in Europe. On 24th June 2018, however, the Bulgarian authorities reported cases of PPR in sheep in the village of Voden, Bolyarovo municipality of Yambol region, on the border with the Thrace region of Turkey. It was the first occurrence of PPR in Bulgaria and in the European Union (EU). The control and eventual eradication of PPR is now one of the top priorities for the Food and Agriculture Organization (FAO) and the World Organization for Animal Health (OIE). In 2015, the international community agreed on a global strategy for PPR eradication, setting 2030 as a target date for elimination of the disease. The aim of this paper was to highlight future research that could be performed to guide and facilitate the PPR eradication programme. Such research includes studies on PPR transmission and epidemiology, as well as the development and application of new-generation PPR vaccines capable of differentiating infected from vaccinated animals (DIVA). Moreover, there is a need for research to improve and adapt existing diagnostic techniques as well as to develop novel PPRV recognition methods, such as a lateral flow device for in-field use, that accelerate decisions about the implementation of control measures.


Author(s):  
Babagana Alhaji Bukar ◽  
Abdul-Dahiru El-Yuguda ◽  
Lawal Said

Peste des petits ruminants is among the most common viral disease conditions of small ruminants, whose status has not yet been reported in Yobe State, Nigeria. Thus, this study was aimed at determining the seroprevalence of this disease among Sahel goats in Yobe State, Nigeria, using competitive enzyme-linked immunosorbent assay (c-ELISA). Out of 460 serum samples collected, 255/460 (55.4%) were positive for PPR antibodies. Seroprevalence rates of 56.1%, 55.4% and 54.6% were recorded in Bursari, Bade and Nangere Local Government Areas (LGAs) respectively. There was no statistically significant difference (p>0.05) observed in the PPRV seroprevalence rates among the three LGAs. Sahel goats older than 18 months had a significantly higher (p<0.0001) Sero-prevalence of 65.2% compared to the 35.3% observed among younger ones (<18 months). The sex-wise distribution of the Peste des petits ruminants virus (PPRV) seroprevalence rate showed that female Sahel goats had 60.0% and the males had 44.6%. The detection of the PPRV among Sahel goats from all the LGAs sampled suggests that PPRV is endemic in the study area. It is therefore recommended that PPR vaccination be instituted in the study areas.


2020 ◽  
Vol 165 (10) ◽  
pp. 2147-2163 ◽  
Author(s):  
William G. Dundon ◽  
Adama Diallo ◽  
Giovanni Cattoli

Abstract Small ruminants (e.g., sheep and goats) contribute considerably to the cash income and nutrition of small farmers in most countries in Africa and Asia. Their husbandry is threatened by the highly infectious transboundary viral disease peste des petits ruminants (PPR) caused by peste-des-petits-ruminants virus (PPRV). Given its social and economic impact, PPR is presently being targeted by international organizations for global eradication by 2030. Since its first description in Côte d’Ivoire in 1942, and particularly over the last 10 years, a large amount of molecular epidemiological data on the virus have been generated in Africa. This review aims to consolidate these data in order to have a clearer picture of the current PPR situation in Africa, which will, in turn, assist authorities in global eradication attempts.


Author(s):  
Allama Prabhu CR

The spread of viral disease in community and its occurrence among healthcare workers is important evidence of person-to-person transition. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared as a pandemic by the WHO. It has affected most of the people and especially the ones with pre-existing medical illness. This prospective study was conducted in a dental college to evaluate impact of the COVID-19 on the knowledge, attitude and practice of the dental students. The students were aware of the Precautions to be taken care of while treating the patients with dental diseases.


2018 ◽  
Vol 92 (24) ◽  
Author(s):  
Sophia Hodgson ◽  
Katy Moffat ◽  
Holly Hill ◽  
John T. Flannery ◽  
Simon P. Graham ◽  
...  

ABSTRACTPeste des petits ruminants (PPR) is a severe disease of goats and sheep that is widespread in Africa, the Middle East, and Asia. Several effective vaccines exist for the disease, based on attenuated strains of the virus (PPRV) that causes PPR. While the efficacy of these vaccines has been established by use in the field, the nature of the protective immune response has not been determined. In addition, while the vaccine derived from PPRV/Nigeria/75/1 (N75) is used in many countries, those developed in India have never been tested for their efficacy outside that country. We have studied the immune response in goats to vaccination with either N75 or the main Indian vaccine, which is based on isolate PPRV/India/Sungri/96 (S96). In addition, we compared the ability of these two vaccines, in parallel, to protect animals against challenge with pathogenic viruses from the four known genetic lineages of PPRV, representing viruses from different parts of Africa, as well as Asia. These studies showed that, while N75 elicited a stronger antibody response than S96, as measured by both enzyme-linked immunosorbent assay and virus neutralization, S96 resulted in more pronounced cellular immune responses, as measured by virus antigen-induced proliferation and interferon gamma production. While both vaccines induced comparable numbers of PPRV-specific CD8+T cells, S96 induced a higher number of CD4+T cells specifically responding to virus. Despite these quantitative and qualitative differences in the immune responses following vaccination, both vaccines gave complete clinical protection against challenge with all four lineages of PPRV.IMPORTANCEDespite the widespread use of live attenuated PPRV vaccines, this is the first systematic analysis of the immune response elicited in small ruminants. These data will help in the establishment of the immunological determinants of protection, an important step in the development of new vaccines, especially DIVA vaccines using alternative vaccination vectors. This study is also the first controlled test of the ability of the two major vaccines used against virulent PPRV strains from all genetic lineages of the virus, showing conclusively the complete cross-protective ability of these vaccines.


Author(s):  
Samuel Mantip ◽  
Melvyn Quan ◽  
David Shamaki ◽  
Moritz Van Vuuren

Peste-des-petits-ruminants virus (PPRV) is a highly contagious, fatal and economically important viral disease of small ruminants that is still endemic and militates against the production of sheep and goats in endemic areas of the world. The aim of this study was to describe the viral strains within the country. This was carried out by collecting tissue and swab samples from sheep and goats in various agro-ecological zones of Nigeria. The phylogeny of archived PPRV strains or isolates and those circulating and causing recent outbreaks was determined by sequencing of the nucleoprotein (N)-gene. Twenty tissue and swab samples from apparently healthy and sick sheep and goats were collected randomly from 18 states, namely 3 states in each of the 6 agro-ecological zones visited. A total of 360 samples were collected. A total of 35 samples of 360 (9.7%) tested positive by reverse transcriptase–polymerase chain reaction, of which 25 were from oculo-nasal swabs and 10 were from tissue samples. Neighbour-joining phylogenetic analysis using Phylogenetic Analysis Using Parsimony (PAUP) identified four different lineages, that is, lineages I, II, III and IV. Interestingly, the Nigerian strains described in this study grouped in two separate major lineages, that is, lineages II and IV. Strains from Sokoto, Oyo, Plateau and Ondo states grouped according to the historical distribution of PPRV together with the Nigerian 75/1 strain of lineage II, while other strains from Sokoto, Oyo, Plateau, Akwa-Ibom, Adamawa, Kaduna, Lagos, Bauchi, Niger and Kano states grouped together with the East African and Asian strains of lineage IV. This finding confirms that both lineage II and IV strains of PPRV are circulating in Nigeria. Previously, only strains of lineage II were found to be present in the country.


2019 ◽  
Vol 75 (02) ◽  
pp. 6209-2019
Author(s):  
WIESŁAW NIEDBALSKI

Peste des petits ruminants (PPR) is a highly contagious disease of small ruminants that leads to high morbidity and mortality, and thereby results in devastating economic consequences to the livestock industry. It is caused by the PPR virus (PPRV), which belongs to the genus Morbilivirus in the family Paramyxoviridae. PPR was first recorded in early 1942 in Ivory Coast, West Africa. In the following years, the disease extended its distribution to other parts of the world and now circulates throughout Northern, Eastern and West Africa, as well as Asia – in particular, China, Central Asia, Eurasia, the Indian subcontinent and the Middle East. The molecular epidemiology of PPRV, based on the sequence comparison of a small region of either the N or the F gene, has revealed the existence of four distinct lineages (I-IV) of the virus. Until June 2018, PPR had never been detected in Europe, with the exception of the European part of Turkish Thrace. However, on 24th June 2018 the Bulgarian authorities reported cases of PPR in sheep in the village of Voden, Bolyarovo municipality of Yambol region, on the border with the Thrace region of Turkey. It was the first occurrence of PPR in Bulgaria and in the European Union (EU). The source of PPR infection in Bulgaria is not clear, it could have been the illegal movement of animals, contaminated materials or humans, e.g. refuges. Due to the increased risk of introduction of PPR from North Africa and Turkey to neighbouring regions, the European Food Safety Authority (EFSA) has recently published a report assessing the risk of PPR spreading in Europe. According to a scientific opinion by the EFSA, the spread of PPRV in the territory of the UE could occur by the illegal transport of infected animals or infected animal products. In order to limit the spread and impact of PPR outbreaks in Europe, rapid detection, movement restriction, prompt culling of infected herds and disinfection measures should be introduced immediately. The control and eventual eradication of PPR is now one of the top priorities for the Food and Agriculture Organization (FAO) and the World Organization for Animal Health (OIE). In 2015, the international community agreed on a global strategy for PPR eradication, setting 2030 as a target date for elimination of the disease.


Sign in / Sign up

Export Citation Format

Share Document